Funding opp: Duke REACH Equity career development award
The Duke Center for REsearch to AdvanCe Healthcare Equity (REACH Equity) is seeking applications for an internal mentored research career development award (CDA) for Duke University junior faculty. Applications are due February 15, 2019. Funding will start July 2019.
2018 GIM Holiday Celebration Recap + Photo Gallery
The division of General Internal Medicine gathered at the Sarah P. Duke Gardens to celebrate the holiday season
Faculty Spotlight: Azalea Kim, MD
We were delighted to receive this interview with Dr. Azalea Kim, a new DGIM faculty member in 2018.
Internal Medicine Residency News, Dec. 10, 2018
Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for Dec. 10, 2018.
Third quarter 2018 - GIM funding awards
Congratulations to these General Internal Medicine faculty members who were recipients of research funding from July through September 2018:
Faculty Spotlight: Sonya Patel-Nguyen, MD
Dr. Sonya Patel-Nguyen joined our division this past July after completing her combined medicine and pediatrics residency training at UNC Chapel Hill.
DGIM holiday celebration 2018
Oh what fun, the DGIM holiday celebration is this week! You don't want to miss it!
The celebration will take place this Thursday, December 13th from 4:30-7:30 PM.
New podcast: Voices of Duke Health
The Voices of Duke Health podcast project, led by Anton Zuiker and Jonathan Bae, MD, has released its first four episodes, including an interview with Yousuf Zafar, MD, associate professor of medicine (Medical Oncology), public policy and population health, on hard conversations with patients and their loved ones.
Duke Study Finds Expanded Cord Blood Shows Potential for Use in Adult Bone Marrow Transplants
A study led by Mitchell Horwitz, MD, professor of medicine (Hematologic Malignancies and Cellular Therapy), has found that umbilical cord blood stem cells that are cultured and expanded outside the body before being used for bone marrow transplant in adult blood cancer patients appear safe and restore blood count recovery faster than standard cord blood. The findings advance efforts to improve cord blood use among adults who have been diagnosed with blood cancers.